New analysis explains why bone marrow cancer T cells may need therapeutic activation

A squad led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V astatine Heidelberg University Hospital (UKHD) has characterized T cells successful the bony marrow of patients with aggregate myeloma and acute myeloid leukemia. The enactment has been published successful Cancer Cell.